Agilent Technologies, Inc. (A) Earnings Call Analysis

NYSE · Healthcare · Diagnostics & Research

25/25

Growth 5 Margin 5 Expansion 5 Platform 5 Financial 5

latest quarter score

Earnings Reports

25
Agilent Technologies (A) Q3 2026: 7.3% Core Revenue Growth Fuels Margin Expansion and Strategic Momentum
August 27, 2026
22
Agilent (A) Q2 2026: Ignite Pricing Delivers 200bps Margin Tailwind, Outpacing End-Market Growth
May 28, 2026
25
Agilent (A) Q1 2026: Advanced Materials Surge 20%, Ignite Drives Margin Expansion Trajectory
February 26, 2026
24
Agilent (A) Q4 2025: Ignite Delivers $150M+ Savings, Margin Expansion Anchors FY26 Guide
November 25, 2025
17
Agilent (A) Q3 2025: Tariff Costs Jump $70M as Ignite Drives 6.1% Core Growth Momentum
August 27, 2025
24
Agilent (A) Q2 2025: Ignite Delivers $130M Profit Amid Tariff Headwinds and 70% PFAS Growth
July 03, 2025
Agilent (A) Q4 2024: Ignite Restructuring Targets 70bps Margin Expansion Amid 400bp Sequential Recovery
November 25, 2024
Agilent (A) Q3 2024: CrossLab Margins Hit 34% as Recurring Revenue Anchors Stability
August 21, 2024
Agilent (A) Q2 2024: $300M Guidance Cut as Pharma and China Headwinds Deepen
May 29, 2024
Agilent (A) Q1 2024: Services Contracts Drive Double-Digit Growth as Instruments Drop 20%
February 27, 2024
Agilent (A) Q4 2023: Free Cash Flow Surges 44% Amid Market Stabilization Signals
November 20, 2023
Agilent Technologies (A) Q3 2023: China Revenue Drops 17%, ResBio Exit Reshapes Margin Path
August 15, 2023
Agilent (A) Q2 2023: Pharma Growth Slows to Low Single Digits as CapEx Pullback Extends Cycle
May 23, 2023
Agilent (A) Q1 2023: Advanced Materials Surge 20%+ as Oligo Expansion and China Drive Growth Visibility
February 28, 2023

Browse all companies